EyeYon Medical has received Investigational Device Exemption (IDE) approval from the U.S. Food and D...

ViaLase has announced the treatment of the first patient in its U.S. Investigational Device Exemptio...

Samsung Bioepis has received a positive opinion from the European Medicines Agency’s Committee for M...

Lotus Pharmaceutical and LENZ Therapeutics have announced the submission of a New Drug Application (...

Kiora Pharmaceuticals has received a new U.S. patent (Patent No. 12,472,263) covering additional and...

Belite Bio has announced promising topline results from its global Phase 3 DRAGON trial, evaluating ...

Sandoz has officially launched Afqlir, its biosimilar referencing aflibercept, across European marke...

Ripple Therapeutics, a clinical-stage company developing polymer-free sustained release drug deliver...

Inflammasome Therapeutics has announced the completion of patient enrollment in its multicenter Phas...

Ocular Therapeutix has announced the randomization of the first patient in HELIOS-3, the second Phas...